DailyStocks Stock Article Search

https://www.fool.com/earnings/call-transcripts/2024/01/31/novartis-ag-nvs-q4-2023-earnings-call-transcript/?source=iedfolrf0000001 Jan 31, 2024 - NVS earnings call for the period ending December 31, 2023. 0

https://seekingalpha.com/article/4667181-euronav-nv-eurn-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Feb 02, 2024 - Euronav NV (NYSE:NYSE:EURN) Q4 2023 Earnings Conference Call February 2, 2024 8:00 AM ETCompany ParticipantsAlexander Saverys - Chief Executive... 0

https://seekingalpha.com/article/4668916-kbc-group-nv-kbcsy-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Feb 08, 2024 - KBC Group NV (OTCPK:KBCSY) Q4 2023 Earnings Conference Call February 8, 2024 3:30 AM ETCompany ParticipantsKurt De Baenst – Investor Relations ManagerJohan... 0

https://www.fool.com/earnings/call-transcripts/2024/02/29/anheuser-busch-inbevnv-bud-q4-2023-earnings-call-t/?source=iedfolrf0000001 Feb 29, 2024 - BUD earnings call for the period ending December 31, 2023. 0

https://seekingalpha.com/article/4675447-bpost-nv-sa-bposf-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Mar 01, 2024 - bpost NV/SA (OTCPK:BPOSF) Q4 2023 Earnings Conference Call March 1, 2024 4:00 AM ETCompany ParticipantsChris Peeters - CEOPhilippe Dartienne - CFOConference... 0

https://seekingalpha.com/article/4678085-agfa-gevaert-nv-afgvf-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Mar 13, 2024 - AGFA Gevaert NV (OTCPK:AFGVF) Q4 2023 Earnings Conference Call March 13, 2024 6:00 AM ETCompany ParticipantsPascal Juery - President, CEO, President,... 0

https://www.fool.com/investing/2024/04/14/looking-for-an-easy-way-to-earn-passive-income-thi/?source=iedfolrf0000001 Apr 14, 2024 - Think globally with this high-yielding ETF. 0

https://www.fool.com/investing/2024/04/17/2-high-yield-dividend-stocks-to-hold-for-10-years/?source=iedfolrf0000001 Apr 17, 2024 - These income stocks look like good options at current levels. 0

https://www.zacks.com/stock/news/2194094/novartis-nvs-gets-fda-nod-for-rare-blood-disorder-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2194094 Dec 06, 2023 - Novartis (NVS) obtains FDA approval for Fabhalta, the first oral monotherapy for treating adults with PNH. 0

https://www.zacks.com/stock/news/2195315/pharma-stock-roundup-abbv-to-buy-cere-jnj-s-2024-view-lly-nvs-get-fda-nod?cid=CS-ZC-FT-analyst_blog|stock_roundup-2195315 Dec 08, 2023 - AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024. 0